Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 10, 2003, Pages 1289-1291

  Xu, Biao ^a   Chibber, Rakesh ^a   Ruggiero, Daniel ^a   Kohner, Eva ^a   Ritter, James ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIBODY; ARGININE; CITRULLINE; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; IMMUNOGLOBULIN RECEPTOR; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ANIMAL; AORTA; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; CELL CULTURE; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FEMORAL ARTERY; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ANTIBODIES; AORTA; ARGININE; BLOOD PRESSURE; CELLS, CULTURED; CITRULLINE; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FEMORAL ARTERY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RABBITS; RECEPTORS, IMMUNOLOGIC; VASODILATION;

MLCS; MLOWN;

EID: 0038265440     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0490fje     Document Type: Article

References (0)